Cross-Border Impact Ventures
Annie Thériault, Managing Partner at Cross-Border Impact Ventures (CBIV), an impact venture capital firm investing in women’s, children’s and adolescents’ health technology companies addressing large international markets. The firm focuses on four verticals, sexual and reproductive health, maternal, newborn and child health, general health and health infrastructure software with an emphasis on expanding access to world class technologies within North America and Europe as well as beyond to reach people living in emerging economies. Throughout her career, Annie has been immersed in impact investing, venture capital, royalty financing, and capital markets. Annie is a thought leader in the field of inclusive health technology investing with a gender and impact lens.
Prior to founding CBIV, Annie worked with high impact companies to mobilize more than $100 million in non-dilutive capital as a venture capital investor and venture advisor. Annie was previously a director on the boards of several North American venture-backed companies, is an advisor to crowdfunding fintech company FrontFundr, and was previously Chief Investment Officer at Grand Challenges Canada. Annie obtained her PhD in Management from the Rotman School of Management at the University of Toronto, is a CFA Charterholder, and holds the ICD.D designation. She also has a master’s degree in Business Economics from Wilfrid Laurier University and a Bachelor of Science with First Class Honours in Chemistry from Mount Allison University.